Authors: Fox, LE Rosenthal, RC King, RR Levine, PB Vail, DM Helfand, SC MacEwen, EG Perez-Soler, R Calderwood-Mays, M Kurzman, ID

Citation: Le. Fox et al., Use of cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II), a liposomal cisplatin analogue, in cats with oral squamous cell carcinoma, AM J VET RE, 61(7), 2000, pp. 791-795

Authors: Soergel, SA MacEwen, EG Vail, DM Potter, DM Sondel, PM Helfand, SC

Citation: Sa. Soergel et al., The immunotherapeutic potential of activated canine alveolar macrophages and antitumor monoclonal antibodies in metastatic canine melanoma, J IMMUNOTH, 22(5), 1999, pp. 443-453

Authors: London, CA Galli, SJ Yuuki, T Hu, ZQ Helfand, SC Geissler, EN

Citation: Ca. London et al., Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit, EXP HEMATOL, 27(4), 1999, pp. 689-697

Authors: Phillips, BS Padilla, ML Dickerson, EB Lindstrom, MJ Helfand, SC

Citation: Bs. Phillips et al., Immunostimulatory effects of human recombinant interleukin-12 on peripheral blood mononuclear cells from normal dogs, VET IMMUNOL, 70(3-4), 1999, pp. 189-201

Authors: Helfand, SC Dickerson, EB Munson, KL Padilla, ML

Citation: Sc. Helfand et al., GD3 ganglioside antibody augments tumoricidal capacity of canine blood mononuclear cells by induction of interleukin 12, CANCER RES, 59(13), 1999, pp. 3119-3127